Identification of Novel High-Frequency DNA Methylation Changes in Breast Cancer
2007

Identifying DNA Methylation Changes in Breast Cancer

Sample size: 230 publication 10 minutes Evidence: high

Author Information

Author(s): Ordway Jared M., Budiman Muhammad A., Korshunova Yulia, Maloney Rebecca K., Bedell Joseph A., Citek Robert W., Bacher Blaire, Peterson Seth, Rohlfing Tracy, Hall Jacqueline, Brown Robert, Lakey Nathan, Doerge Rebecca W., Martienssen Robert A., Leon Jorge, McPherson John D., Jeddeloh Jeffrey A.

Primary Institution: Orion Genomics, St. Louis, Missouri, United States of America

Hypothesis

Can genome-wide analysis of DNA methylation alterations identify novel biomarkers for breast cancer?

Conclusion

The study identified over 50 novel DNA methylation-based biomarkers for breast cancer, which may improve early detection and understanding of tumorigenesis.

Supporting Evidence

  • The study identified approximately 200 differentially methylated loci.
  • Validation was performed across a panel of over 230 clinical samples.
  • The GHSR gene locus distinguished breast cancer from normal tissues with 90% sensitivity and 96% specificity.
  • Hypermethylation events were independent of patient age and tumor stage.
  • Over 50 novel DNA methylation-based biomarkers were discovered.
  • DNA methylation changes were confirmed by quantitative PCR and bisulfite sequencing.
  • Results suggest potential for non-invasive cancer detection methods.

Takeaway

Researchers found new markers in DNA that can help detect breast cancer early, which is important for better treatment.

Methodology

A microarray-based strategy was used for comprehensive DNA methylation profiling in breast cancer tissues.

Potential Biases

Potential bias in sample selection and the specificity of the biomarkers identified.

Limitations

The study may not account for all genetic variations and the sample size, while large, may not represent all breast cancer types.

Participant Demographics

Participants included women aged 32 to 57 with infiltrating ductal breast carcinoma.

Statistical Information

P-Value

0.64

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001314

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication